Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$225K Hold
1,900
0.02% 183
2026
Q1
$227K Hold
1,900
0.03% 179
2025
Q4
$259K Hold
1,900
0.03% 159
2025
Q3
$280K Hold
1,900
0.04% 151
2025
Q2
$246K Sell
1,900
-1,800
-49% -$218K 0.04% 157
2025
Q1
$442K Buy
3,700
+2,300
+164% +$285K 0.08% 124
2024
Q4
$162K Buy
+1,400
New +$177K 0.03% 183

Other funds holding XYL

Sava Infond's XYL Position: Q2 2026 in Review

Sava Infond held its Xylem (XYL) position steady in Q2 2026 at 1,900 shares worth $225K. The position accounts for 0.02% of the portfolio, ranked #183.

Sava Infond first reported a position in XYL in Q4 2024 and has held it in 7 quarters since. The position peaked at $442K in Q1 2025. 188 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • Sava Infond held 1,900 shares of Xylem worth $225K as of Q2 2026.
  • Sava Infond left its Xylem share count unchanged in Q2 2026.
  • Xylem made up 0.02% of Sava Infond's portfolio in Q2 2026, its #183 holding.
  • Sava Infond first reported a position in Xylem in Q4 2024 and has held it in 7 quarters since.
  • Sava Infond's Xylem position peaked at $442K in Q1 2025.
  • 188 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Sava Infond's 13F filing for Q2 2026, filed 16 Jul 2026.